FDA Adverse Event Injury Summary report: N

REPLY

MDR report key: 10697717 · Received October 19, 2020

Report

Report Number
1000165971-2020-00653
Event Type
Injury
Date Received
October 19, 2020
Date of Event
September 17, 2020
Report Date
December 8, 2020
Manufacturer
MICROPORT CRM S.R.L.
Product Code
NVZ
PMA / PMN Number
P950029
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

PLEASE REFER TO THE ATTACHED ANALYSIS REPORT.

Description of Event or Problem · 0

REPORTEDLY, ON (B)(6) 2020 AROUND 13:10, THE MESSAGE 'DEVICE RESET WAS NEEDED' WAS DISPLAYED ON THE PROGRAMMER. THE PACEMAKER WAS RE-INITIALIZED AND PROGRAMMED IN SAFER-R MODE IN BIPOLAR CONFIGURATION. OVERSENSING WAS OBSERVED IN AN EPISODE RECORDED IN THE DEVICE MEMORIES. LEADS IMPEDANCES, PACING AND SENSING THRESHOLDS WERE ALL NORMAL AND THE PATIENT WAS PUT UNDER OBSERVATION.

Description of Event or Problem · 1

REPORTEDLY, ON (B)(6) 2020 AROUND 13:10, THE MESSAGE 'DEVICE RESET WAS NEEDED' WAS DISPLAYED ON THE PROGRAMMER. THE PACEMAKER WAS RE-INITIALIZED AND PROGRAMMED IN SAFER-R MODE IN BIPOLAR CONFIGURATION. OVERSENSING WAS OBSERVED IN AN EPISODE RECORDED IN THE DEVICE MEMORIES. LEADS IMPEDANCES, PACING AND SENSING THRESHOLDS WERE ALL NORMAL AND THE PATIENT WAS PUT UNDER OBSERVATION. PRELIMINARY ANALYSIS RESULTS CONFIRMED THE REPORTED SWITCH IN STANDBY MODE, MOST PROBABLY DUE TO A SINGLE EVENT UPSET (SEU). THE DEVICE WAS PROPERLY RE-INITIALIZED DURING THE FOLLOW-UP PERFORMED ON (B)(6) 2020 AND ITS NORMAL FUNCTIONING WAS RESTORED. BASED ON PRELIMINARY ANALYSIS, IT IS SUSPECTED THAT THE OVERSENSING EPISODE IS MOST PROBABLY RELATED TO THE ACTIVATION OF THE MV SENSOR DURING THE FOLLOW-UP PERFORMED ON (B)(6) 2020. HOWEVER ATRIAL AND VENTRICULAR LEADS ISSUES COULD NOT BE EXCLUDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1163022 REPLY PULSE GENERATOR, PERMANENT, IMPLANTABLE NVZ MICROPORT CRM S.R.L. REPLY DR 2653

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention